Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
22nd February 2018
This week, we welcome the Optos California scanner to the practice, continuing our commitment to ensure we always have the latest technology available. We are the first optometry practice in Scotland ...Read more
15th February 2018
We are thrilled to announce that we have been shortlisted for two categories in the highly regarded national UK Optician Awards. Recognised as the benchmark of excellence in the optical community, the...Read more
29th January 2018
Heather Muir has completed further training to ensure Cameron Optometry continues to provide highest level of care to young patients, in particular those transitioning to contact lens wear. Last y...Read more